NURE 📈 Nuveen Short-Term REIT - Overview
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US67092P7069 • Real Estate
NURE: Real Estate, Investment Trusts, US Equities
The fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in REITs. The index is a subset of the Dow Jones U.S. Select REIT Index, which generally includes equity REITs traded on a national securities exchange in the U.S. that derive at least 75% of their total revenue from the ownership and operation of real estate assets and that have a minimum total market capitalization of $200 million at the time of their inclusion. It is non-diversified. ‣ Company URL: http://www.nuveen.com ‣ Domicile: United States
Additional Sources for NURE ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NURE ETF Overview
| Market Cap in USD | 52m |
| Category | Real Estate |
| TER | 0.35% |
| IPO / Inception | 2016-12-19 |
NURE ETF Ratings
| Growth 5y | 35.3% |
| Fundamental | - |
| Dividend | 49.6% |
| Rel. Strength Industry | 26.9 |
| Analysts | - |
| Fair Price Momentum | 30.03 USD |
| Fair Price DCF | - |
NURE Dividends
| Dividend Yield 12m | 2.58% |
| Yield on Cost 5y | 3.16% |
| Annual Growth 5y | 3.05% |
| Payout Consistency | 81.4% |
NURE Growth Ratios
| Growth Correlation 3m | 2.7% |
| Growth Correlation 12m | 85.3% |
| Growth Correlation 5y | 45.9% |
| CAGR 5y | 4.13% |
| CAGR/Mean DD 5y | 0.25 |
| Sharpe Ratio 12m | 0.20 |
| Alpha | -22.33 |
| Beta | 1.13 |
| Volatility | 34.38% |
| Current Volume | 7.8k |
| Average Volume 20d | 6.1k |
What is the price of NURE stocks?
As of December 22, 2024, the stock is trading at USD 31.74 with a total of 7,800 shares traded.
Over the past week, the price has changed by -4.57%, over one month by -4.14%, over three months by -8.13% and over the past year by +8.20%.
As of December 22, 2024, the stock is trading at USD 31.74 with a total of 7,800 shares traded.
Over the past week, the price has changed by -4.57%, over one month by -4.14%, over three months by -8.13% and over the past year by +8.20%.
Is Nuveen Short-Term REIT a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Nuveen Short-Term REIT (BATS:NURE) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.27 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NURE as of December 2024 is 30.03. This means that NURE is currently overvalued and has a potential downside of -5.39%.
Partly, yes. Based on ValueRay Analyses, Nuveen Short-Term REIT (BATS:NURE) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.27 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NURE as of December 2024 is 30.03. This means that NURE is currently overvalued and has a potential downside of -5.39%.
Is NURE a buy, sell or hold?
Nuveen Short-Term REIT has no consensus analysts rating.
Nuveen Short-Term REIT has no consensus analysts rating.
What are the forecast for NURE stock price target?
According to ValueRays Forecast Model, NURE Nuveen Short-Term REIT will be worth about 33.5 in December 2025. The stock is currently trading at 31.74. This means that the stock has a potential upside of +5.64%.
According to ValueRays Forecast Model, NURE Nuveen Short-Term REIT will be worth about 33.5 in December 2025. The stock is currently trading at 31.74. This means that the stock has a potential upside of +5.64%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 33.5 | 5.6% |